PGP and hepatocellular carcinoma: Meanwhile, cinobufotalin is also uncovered to reverse multidrug resistance of tumors including HCC, such as it can reverse the adriamycin resistance in Raji/ADR cells and the expression of P-gp and MRP-1 protein (33, 34).